WATCH: Trump signs executive order speeding up research on using psychedelics for mental health

mental-health

President Donald Trump signed an executive order allowing expedited reviews of psychedelic drugs for medical purposes, including mental health conditions. The order, titled “Accelerating Medical Treatments For Serious Mental Illnesses,” seeks to address the “burden of suicide and serious mental illness rates in America” by allowing psychedelics, including the Schedule I-classified ibogaine, to be researched and used in specific cases. Trump stated: “Today’s order will ensure that people suffering from debilitating symptoms might finally have a chance to reclaim their lives and lead a happier life.”

Podcaster Joe Rogan and former Navy SEAL Marcus Luttrell joined Trump and HHS Secretary Robert F. Kennedy Jr. for the signing ceremony. Rogan stated that he sent Trump information about ibogaine’s effects, saying the response came back: “Sounds great! Do you want FDA approval? Let’s do it! It was literally that quick.” He noted that in 2024, more than 80,000 people died of overdoses, with more than 5 million people addicted to opioids in the country. According to Rogan, “With one dose of ibogaine, more than 80% of people are free of that addiction. With two doses, it’s more than 90%.”

The order directs HHS to collaborate with the Department of Veterans Affairs and the private sector to “increase clinical trial participation, data-sharing and real-world evidence” regarding psychedelic use. Section 2 of the order allows the FDA to extend “right to try” provisions to psychedelic drugs, including ibogaine compounds, for eligible patients with certain diagnoses. The order states: “Psychedelic drugs, including ibogaine compounds, show potential in clinical studies to address serious mental illnesses for patients whose conditions persist after completing standard therapy. Indeed, the Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to specific psychedelic drugs, and there are numerous products currently in the clinical trial pipeline for review of safety and efficacy.”


This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://www.wnd.com/2026/04/watch-trump-signs-executive-order-speeding-up-research/